Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Reflect ScientificRSCF +6.26% EV-to-EBITDA is 60.69 as of Jul. 15, 2026. The stock has 4 warning signs investors should review. Among 511 Medical Devices & Instruments companies, Reflect Scientific ranks worse than 90.61% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Reflect Scientific's enterprise value is $2.12 Mil.
Reflect Scientific's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $0.04 Mil. Therefore, Reflect Scientific's EV-to-EBITDA for today is 60.69.
The historical rank and industry rank for Reflect Scientific's EV-to-EBITDA or its related term are showing as below:
RSCF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -367.45 Med: -8.05 Max: 8118
Current: 60.71
During the past 13 years, the highest EV-to-EBITDA of Reflect Scientific was 8118.00. The lowest was -367.45. And the median was -8.05.
RSCF's EV-to-EBITDA is ranked worse than 90.61% of 511
companies
in the Medical Devices & Instruments industry
Industry Median: 14.2
vs RSCF: 60.71
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Reflect Scientific's PE Ratio (TTM) for today is calculated as:
Reflect Scientific's share price for today is $0.04277.
Reflect Scientific's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Reflect Scientific's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Reflect Scientific's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's EV-to-EBITDA falls into.
Reflect Scientific's current Enterprise Value is $2.12 Mil.
Reflect Scientific's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Reflect Scientific (RSCF) has a EV-to-EBITDA of 60.69 as of Jul. 15, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Reflect Scientific. According to the industry distribution chart, Reflect Scientific ranks #463 out of 511 companies in the Medical Devices & Instruments industry, placing it in the top 90.6%.
Is Reflect Scientific's EV-to-EBITDA too high?
Reflect Scientific's current EV-to-EBITDA is 60.69. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.20. Reflect Scientific's value of 60.69 is 327.4% above this industry median. Based on the distribution chart, Reflect Scientific ranks #463 out of 511 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Reflect Scientific's EV-to-EBITDA compare to NXGL and LUCY?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #463 out of 511 companies for EV-to-EBITDA. This places Reflect Scientific in the lower half of its industry. The industry median EV-to-EBITDA is 14.20. Reflect Scientific's value of 60.69 is 327.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.20, based on 511 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current EV-to-EBITDA of 60.69 is 327.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Reflect Scientific. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current EV-to-EBITDA is 60.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current EV-to-EBITDA of 60.69. The current EV-to-EBITDA is 60.69 and 327.4% above the Medical Devices & Instruments industry median of 14.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current EV-to-EBITDA is 60.69 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 
